Your browser doesn't support javascript.
loading
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study.
Zheng, Hong; Cao, Yunlong; Chen, Xiaosu; Wang, Fengmei; Hu, Ye; Song, Weiliang; Chai, Yangyang; Gu, Qingqing; Shi, Yansong; Feng, Yingmei; Liu, Shuxun; Xie, Yan; Xie, Xiaoliang Sunney; Jiang, Wentao; Shen, Zhongyang.
Afiliação
  • Zheng H; Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China.
  • Cao Y; Changping Laborarty, Beijing, China. yunlongcao@pku.edu.cn.
  • Chen X; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China. yunlongcao@pku.edu.cn.
  • Wang F; Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, China.
  • Hu Y; Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China.
  • Song W; Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, China.
  • Chai Y; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
  • Gu Q; Department of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
  • Shi Y; Changping Laborarty, Beijing, China.
  • Feng Y; Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, China.
  • Liu S; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Xie Y; National Key Laboratory of Medical Immunology, Institute of Immunology, Navy Medical University, Shanghai, China.
  • Xie XS; Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China.
  • Jiang W; Changping Laborarty, Beijing, China.
  • Shen Z; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
Cell Res ; 32(8): 781-784, 2022 08.
Article em En | MEDLINE | ID: mdl-35672387
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Vacinação / Anticorpos Neutralizantes Tipo de estudo: Observational_studies País/Região como assunto: Asia Idioma: En Revista: Cell Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Vacinação / Anticorpos Neutralizantes Tipo de estudo: Observational_studies País/Região como assunto: Asia Idioma: En Revista: Cell Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China